Patent details

Basic Information

Publication number:

EP2846809

PCT Application Number:

US2013031053

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137876512

PCT Publication Number:

WO2013169355

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF MYELOSUPPRESSION

French Title of Invention:

TRAITEMENT DE LA MYÉLOSUPPRESSION

German Title of Invention:

BEHANDLUNG VON MYELOSUPPRESSION

SPC Number:

Dates

Filing date:

13/03/2013

Grant date:

14/10/2020

EP Publication Date:

18/03/2015

PCT Publication Date:

14/11/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/10/2020

EP B1 Publication Date:

14/10/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/03/2023

Expiration date:

13/03/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/10/2020

 

 

Name:

Cantex Pharmaceuticals, Inc.

Address:

1792 Bell Tower Lane, Weston, Florida 33326, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

11/01/2021

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

MARCUS, Stephen

Address:

United States (US)

Priority

1

Priority Number:

201261644623 P

Priority Date:

09/05/2012

Priority Country:

United States (US)

2

Priority Number:

201261644556 P

Priority Date:

09/05/2012

Priority Country:

United States (US)

3

Priority Number:

201261648043 P

Priority Date:

16/05/2012

Priority Country:

United States (US)

4

Priority Number:

201261653362 P

Priority Date:

30/05/2012

Priority Country:

United States (US)

5

Priority Number:

201261664611 P

Priority Date:

26/06/2012

Priority Country:

United States (US)

6

Priority Number:

201261668709 P

Priority Date:

06/07/2012

Priority Country:

United States (US)

7

Priority Number:

201261678053 P

Priority Date:

31/07/2012

Priority Country:

United States (US)

8

Priority Number:

201261702207 P

Priority Date:

17/09/2012

Priority Country:

United States (US)

9

Priority Number:

201261724836 P

Priority Date:

09/11/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/715; A61K 31/727; A61K 45/06; A61P 7/00; C08B 37/10;

Publication

European Patent Bulletin

Issue number:

202042

Publication date:

14/10/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

02/03/2022

Last Annual Fee Paid Number:

10

Last Annual Fee Paid Amount:

131 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
11/01/2021	Power Of Attorney	1
13/01/2021	Outgoing Correspondence	1